Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/37996
Title: Preclinical efficacy of direct AMPK activation with a novel small molecule -PXL770- for the treatment of autosomal dominant polycystic kidney disease
Authors: Dagorn, Pascale Gluais
Buchholz, Bjoern
Bange, Hester
BLOCKKEN, Laura 
Moller, David E.
Hallakou-Bozec, Sophie
Issue Date: 2022
Publisher: OXFORD UNIV PRESS
Source: NEPHROLOGY DIALYSIS TRANSPLANTATION, 37 (Art N° MO019)
Document URI: http://hdl.handle.net/1942/37996
ISSN: 0931-0509
e-ISSN: 1460-2385
ISI #: 000813350700020
Rights: The Author(s) 2022. Published by Oxford University Press on behalf of the ERA. This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
Category: M
Type: Journal Contribution
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
RENAL DEVELOPMENT AND CYSTIC DISEASES.pdf
  Restricted Access		Published version83.71 kBAdobe PDFView/Open    Request a copy
Show full item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.